Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Returns by 2028 Micron on Track for Best Monthly Rally Since 1987 Analysts Suggest Further Upside Potential White House and China Announce Trade Deals on Soybeans and Rare Earths Following TrumpXi Summit Consumer Credit Growth Surges in December Amid Holiday Spending JK Cement Posts 13 Volume Growth in Q4FY26 Outpacing Industry Amid Rising Cost Pressures Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Beat Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances Guidewire Q1 2026 Earnings EPS Surges Past Estimates by 484 as Operating Performance Strengthens MRTN Q1 2026 Earnings EPS Beats Estimates by 1765 Shares Edge Higher AMSC Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism Everus Construction Group ECG Holds Steady Near Key Support After Modest Decline Brookfield Renewable Partners BEP Edges Higher as It Holds Above Key Support Bassett Furniture BSET Holds Steady Near Resistance as Volume Signals Caution ONEOK Inc OKE Holds Steady Near Support Level Amid Modest Pullback Phio Pharmaceuticals PHIO Holds Ground Modest Gain Amid Key Technical Levels Ready Capital Corporation 620 Senior Notes due 2026 RCB Q1 2026 Earnings Significant EPS Miss Highlights Challenges Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure Autohome Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Dips Tiptree Inc TIPT Q2 2025 Earnings Solid EPS Performance Despite Revenue Opacity SO Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh Marvell United Airlines and Zscaler Lead Market Movers as Investors Assess Sector Trends PEW Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress Artelo Biosciences ARTL Gains 735 Biotech Stock Tests Resistance Near 153